Misclassification of the actual causes of death and its impact on analysis: A case study in non-small cell lung cancer Journal Article


Author: Tan, K. S.
Article Title: Misclassification of the actual causes of death and its impact on analysis: A case study in non-small cell lung cancer
Abstract: Objectives: Cumulative incidence of lung cancer deaths (LC-CID)is an important metric to understand cancer prognosis and to determine treatment options. However, credible estimates of LC-CID rely on accurate cause-of-death coding in death certificates. Results from lung cancer screening trials estimated 15% under-reporting and 1% over-reporting of lung cancer deaths due to misclassification. This study investigated the impact of cause-of-death misclassification on the estimation of LC-CID. Materials and Methods: Patients with stage I/II non-small cell lung cancer (NSCLC)from the Surveillance, Epidemiology, and End Results registry were included. LC-CID was estimated using the competing-risk approach in two ways: (1)reporting observed estimates that ignore potential cause-of-death misclassification and (2)correcting for plausible misclassification rates reported in the literature (15% under-reporting and 1% over-reporting). Bias was quantified as the difference between observed and corrected 10-year LC-CIDs: positive values indicated that observed LC-CID overestimated true LC-CID, whereas negative values indicated the opposite. Results: Among 66,179 patients, the impact of over-reporting on 10-year LC-CID was negligible across all age groups. In contrast, under-reporting resulted in substantial underestimation of 10-year LC-CID. The biases increased as age increased due to higher LC-CIDs: 10-year LC-CIDs among stage I patients 18-44, 45-59, 60-74 and ≥75 years were 25%, 32%, 41%, and 50%, respectively, and the corresponding biases given the plausible misclassification rates were -4.4%, -5.6%, -7.1%, and -8.6%. Because the observed LC-CIDs among patients with stage II disease were higher than those with stage I disease, the biases were greater among stage II patients, up to -12.5% in the oldest age group. Conclusions: In lung cancer, LC-CID may be severely underestimated due to under-reporting of lung cancer deaths, particularly among older patients or those with late-stage disease. Future studies that involve such subpopulations should present the corrected LC-CIDs based on plausible misclassification rates alongside the observed LC-CIDs. © 2019 Elsevier B.V.
Keywords: cause-specific survival; cumulative incidence; death certificate; competing risk events; cause of failure
Journal Title: Lung Cancer
Volume: 134
ISSN: 0169-5002
Publisher: Elsevier Ireland Ltd.  
Date Published: 2019-08-01
Start Page: 16
End Page: 24
Language: English
DOI: 10.1016/j.lungcan.2019.05.016
PROVIDER: scopus
PMCID: PMC6650158
PUBMED: 31319976
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kay See   Tan
    241 Tan